Sacral neuromodulation for persistent faecal incontinence after laparoscopic ventral rectopexy for high‐grade internal rectal prolapse

Mishra, Ami; Prapasrivorakul, Siriluck; Gosselink, M.; Gorissen, K.; Hompes, Roel; Jones, Oliver; Cunningham, Chris; Matzel, Klaus E.; Lindsey, Ian

doi:10.1111/codi.13125

Cited by 13 publications

(6 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A second subgroup, separately demonstrated in Table 4 , are patients with fecal incontinence [ 1 – 3 , 7 , 8 , 32 , 33 , 37 , 40 ]. Eight publications focused on this entity covering 1525 patients.…”

Section: Resultsmentioning

confidence: 99%

Quality of life in benign colorectal disease—a review of the assessment with the Gastrointestinal Quality of Life Index (GIQLI)

Fuchs,

Musial,

Retzbach

et al. 2023

Int J Colorectal Dis

View full text Add to dashboard Cite

Background and purpose The Gastrointestinal Quality of Life Index (GIQLI) is an instrument for the assessment of quality of life (QOL) in diseases of the upper and lower GI tract, which is validated in several languages around the world. The purpose of this literature review is the assessment of the GIQLI in patients with benign colorectal diseases. Reports on GIQLI data are collected from several institutions, countries, and different cultures which allows for comparisons, which are lacking in literature. Methods The GIQL Index uses 36 items around 5 dimensions (gastrointestinal symptoms (19 items), emotional dimension (5 items), physical dimension (7 items), social dimension (4 items), and therapeutic influences (1 item). The literature search was performed on the GIQLI and colorectal disease, using reports in PubMed. Data are presented descriptively as GIQL Index points as well as a reduction from 100% maximum possible index points (max 144 index points = highest quality of life). Results The GIQLI was found in 122 reports concerning benign colorectal diseases, of which 27 were finally selected for detailed analysis. From these 27 studies, information on 5664 patients (4046 female versus 1178 male) was recorded and summarized. The median age was 52 years (range 29–74.7). The median GIQLI of all studies concerning benign colorectal disease was 88 index points (range 56.2–113). Benign colorectal disease causes a severe reduction in QOL for patients down to 61% of the maximum. Conclusions Benign colorectal diseases cause substantial reductions in the patient’s QOL, well documented by GIQLI, which allows a comparison QOL with other published cohorts.

show abstract

Section: Resultsmentioning

confidence: 99%

Quality of life in benign colorectal disease—a review of the assessment with the Gastrointestinal Quality of Life Index (GIQLI)

Fuchs,

Musial,

Retzbach

et al. 2023

Int J Colorectal Dis

View full text Add to dashboard Cite

show abstract

“…In at least 1 study, SNS has demonstrated success among patients with persistent FI after ventral rectopexy, with improvements in FI and quality of life on the order of magnitude for other patients undergoing the procedure. 26 There are no direct comparisons between SNS and ventral rectopexy in part because the procedures are not equivalent. Like SNS, ventral rectopexy appears to improve FI symptoms for patients with RAI by 40% to 50%.…”

Section: Discussionmentioning

confidence: 99%

Does Rectoanal Intussusception Limit Improvements in Clinical Outcome and Quality of Life After Sacral Nerve Stimulation for Fecal Incontinence?

Mariscal

White

Sirany

et al. 2023

Diseases of the Colon &Amp; Rectum

View full text Add to dashboard Cite

BACKGROUND: Sacral nerve stimulation is a treatment option for severe, medically refractory fecal incontinence, although its use in patients with anatomic abnormalities remains controversial. OBJECTIVE:This study aimed to determine whether patients with rectoanal intussusception achieve similar benefits from device implantation to patients without rectoanal intussusception. DESIGN:Retrospective review of a prospectively maintained database. Demographics and clinical data were collected for each patient, including preoperative pelvic floor testing. Defecographies were reanalyzed in a blinded manner. Preoperative rectoanal intussusception was determined on the basis of the Oxford system (grade III-IV vs not; grade V excluded).SETTINGS: Academic-affiliated pelvic health center.

show abstract

“…36 Furthermore, Mishra et al demonstrated that some patients who underwent laparoscopic ventral rectopexy for both severe internal rectal prolapse and impaired anal continence might suffer from persistent symptoms of impaired continence after surgery. 37 Delorme's procedure is a completely manual transanal operation that was first described to treat external rectal prolapse and then modified in the internal Delorme's procedure to additionally treat internal rectal intussusception and rectocele that induce ODS. It has already been reported in the literature that the internal Delorme's procedure has good results and similar improvement in ODS symptoms compared to the stapled procedure.…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Internal Delorme’s Procedure for Treating ODS Associated With Impaired Anal Continence

et al. 2017

View full text Add to dashboard Cite

show abstract

Sacral neuromodulation for persistent faecal incontinence after laparoscopic ventral rectopexy for high‐grade internal rectal prolapse

Abstract: Patients may benefit from sacral neuromodulation for persisting faecal incontinence after laparoscopic ventral rectopexy.

Cited by 13 publications

References 34 publications

Quality of life in benign colorectal disease—a review of the assessment with the Gastrointestinal Quality of Life Index (GIQLI)

Quality of life in benign colorectal disease—a review of the assessment with the Gastrointestinal Quality of Life Index (GIQLI)

Does Rectoanal Intussusception Limit Improvements in Clinical Outcome and Quality of Life After Sacral Nerve Stimulation for Fecal Incontinence?

Internal Delorme’s Procedure for Treating ODS Associated With Impaired Anal Continence

Contact Info

Product

Resources

About